News/ R&D/ Views and analysis R&D Roundup: Novartis pipeline, CRISPR funding and Opdivo disappointments George Underwood CRISPR, Ketyruda, Novartis, Opdivo, R&D Roundup 0 Comment Novartis has showcased its pipeline at its annual meet-the-management day, where investors and analysts got to hear company Share X R&D Roundup: Novartis pipeline, CRISPR funding and Opdivo disappointments https://pharmaphorum.com/views-and-analysis/rd-roundup-novartis-crispr-opdivo/
